NATIONAL HEALTHCARE (NHC) director sells 7,500 shares, retains options
Richard F. LaRoche Jr., a director at NATIONAL HEALTHCARE CORP (NHC), sold 7,500 shares of common stock at $195.1421 per share in an open-market transaction. Following this sale, he still directly holds 205,760 common shares. LaRoche also retains multiple option awards for 7,500 underlying shares each, granted between 2022 and 2026, with expiration dates extending through 2031.
NHC (NYSE: NHC) CEO reports 26-share gift and details option holdings
National Healthcare Corp (NHC) CEO Stephen Fowler Flatt reported a bona fide gift of 26 common shares, reducing his direct holdings to 66,987 shares. The filing also detailed his outstanding stock option awards, including 20,000 shares at $157.13, 12,000 shares at $90.62, 5,000 shares at $94.10, and 4,294 shares at $53.94, with various expiration dates. This Form 4 primarily serves to update his direct share ownership and current option positions, with no open-market buys or sells reported.
[144] NATIONAL HEALTHCARE CORP SEC Filing
This article announces a Form 144 SEC filing by NATIONAL HEALTHCARE CORP (NHC) on May 21, 2026. The filing indicates a proposed sale of 7500 shares of common stock with an aggregate market value of $1,463,155.33 by an individual via UBS Financial Services Inc. The shares were acquired on May 6, 2026, through an options exercise from National HealthCare Corporation.
National HealthCare Corp stock hits all-time high of 185.6 USD
National HealthCare Corp (NHC) stock has reached an all-time high of $185.60, demonstrating significant growth with an 84.7% one-year total return and a market capitalization of $2.86 billion. The company has also announced the acquisition of 32 skilled nursing facilities and three independent living facilities for $560 million, declared a quarterly dividend of 64 cents per common share, and National Healthcare Properties Inc. is moving forward with its IPO. NHC boasts a "GREAT" financial health score and high returns over the last decade, according to InvestingPro data.
Insider Sell: Timothy Shelly Sells Shares of National Healthcare Corp (NHC)
Timothy Shelly, Senior Vice President of Operations at National HealthCare Corporation, sold 1,853 shares of NHC on May 19, 2026, reducing his holdings to 1,294 shares. Over the past year, Shelly has sold a total of 4,307 shares, with no insider purchases recorded. The company's stock is currently trading at $197.22, indicating it is significantly overvalued with a price-to-GF-Value ratio of 1.56, based on a GF Value of $126.40.
National HealthCare Corp stock hits all-time high at 199.7 USD
National HealthCare Corp (NHC) stock reached an all-time high of $199.7, reflecting an 88.62% increase over the past year. The company has raised its dividend for 12 consecutive years and recently announced the acquisition of 35 senior care facilities for $560 million. Despite appearing overvalued by some analyses, NHC's strategic moves and strong performance indicate sustained investor confidence.
National Healthcare Corp (NHC) senior VP sells shares and details option holdings
National Healthcare Corp's Senior VP of Operations, Timothy J. Shelly, sold 1,853 shares of common stock for approximately $365,444 and now directly holds 1,294 shares. The filing also detailed his various outstanding stock option awards, which cover a significant number of shares with varying exercise prices and expiration dates. This transaction is considered a routine insider sale, not indicative of a major change in company outlook.
National HealthCare Corp stock hits all-time high at 199.7 USD
National HealthCare Corp (NHC) stock has reached an all-time high of 199.7 USD, marking an 88.62% increase over the past year. The company has consistently raised its dividend for 12 years and has announced the acquisition of 35 senior care facilities for $560 million. Despite its strong performance, InvestingPro's Fair Value analysis suggests the stock is currently overvalued.
National HealthCare Corp stock hits all-time high at 199.7 USD
National HealthCare Corp's stock has reached an all-time high of $199.7 USD, reflecting an 88.62% increase over the past year and nearly 44% year-to-date gains. The company has also consistently raised its dividend for 12 consecutive years. Despite appearing overvalued by InvestingPro's analysis, the company continues strategic moves including a significant acquisition of 35 senior care facilities for $560 million, and shareholders recently re-elected key board members.
National HealthCare Corp. completes $50.5M acquisition of 5 SNFs from National Health Investors
National HealthCare Corp. (NHC) has completed the acquisition of five skilled nursing facilities (SNFs) from National Health Investors (NHI) for $50.5 million. This acquisition is part of a larger agreement for NHC to purchase 32 SNFs and three independent living communities from NHI for $560 million. The sale is expected to close in the second quarter, enabling NHI to reduce its exposure to skilled nursing and focus on senior housing.
NHC (NYSE: NHC) CEO exercises options as 4,492 shares withheld for taxes
National Healthcare Corp's CEO, Stephen Fowler Flatt, exercised 6,000 stock options at strike prices of $90.62 and $94.10. The company withheld 4,492 shares to cover the exercise price and related tax obligations. Following these transactions, Flatt directly holds 67,013 common shares and retains unexercised options for over 20,000 shares at $157.13 and 4,294 shares at $53.94, with expiration dates stretching to 2031.
NHC (NHC) CFO Kidd exercises stock options and settles taxes in shares
National Healthcare Corp's SVP and CFO, Brian F. Kidd, exercised stock options for 4,500 shares and had 3,134 shares withheld to cover the exercise price and tax obligations. These transactions were compensation-related under the 2020 Omnibus Equity Incentive Plan. Kidd still holds unexercised options for 14,000 and 4,147 shares at different exercise prices.
National HealthCare (NYSE: NHC) signs $50.5M deal for five skilled nursing facilities
National HealthCare Corporation (NHC) announced that its subsidiary, NHC/OP, L.P., will acquire five skilled nursing facilities for $50.5 million from National Health Corporation. These facilities are currently managed by NHC affiliates. The deal is subject to financing, regulatory approvals, and an inspection period and is expected to close in the second quarter of 2026.
National HealthCare (NYSE: NHC) details 2026 director and pay vote outcomes
National HealthCare Corporation announced the results of its Annual Meeting of Shareholders held on May 7, 2026. Shareholders re-elected three directors for three-year terms and approved, on an advisory basis, the compensation of the Named Executive Officers. A quorum was established with 12,216,578 shares represented out of 15,599,046 shares outstanding as of the record date.
Vanguard Group Inc. Has $193.56 Million Holdings in National HealthCare Corporation $NHC
Vanguard Group Inc. slightly reduced its stake in National HealthCare Corporation in Q4 but still holds 1.41 million shares valued at $193.6 million, representing 9.1% of the company. National HealthCare reported strong quarterly results with $1.91 EPS and $381.82 million in revenue, along with an increase in its quarterly dividend to $0.67 per share. Institutional investors and hedge funds collectively own 56.44% of National HealthCare's stock.
National HealthCare: Q1 Earnings Snapshot
National HealthCare Corp. (NHC) reported first-quarter earnings of $35.9 million, or $2.27 per share. Adjusted for non-recurring gains, the company earned $1.91 per share. The nursing home and assisted living company also recorded revenue of $381.8 million for the period.
NATIONAL HEALTHCARE CORP (NHC) director exercises options, now holds 10,640 shares
NATIONAL HEALTHCARE CORP (NHC) director Sandra Y. Trail exercised stock options on May 6, 2026, acquiring 3,140 shares at $55.75 per share, increasing her direct holdings to 10,640 shares. She still retains significant option grants from 2023, 2024, 2025, and 2026, with various exercise prices and expiration dates. The transaction is compensation-related, falling under the company's 2020 Omnibus Equity Incentive Plan and exempt from Section 16(b).
National Healthcare (NYSE: NHC) corrects director option grant price
National Healthcare Corp (NYSE: NHC) has issued a Form 4/A to correct the exercise price for options granted to director William A. Adams. The filing clarifies that 7,500 shares were granted with an exercise price of $171.42 per share, matching the closing price on May 7, 2026, correcting a previous error where the price was reported as $0.00. The options are set to expire on May 6, 2030.
Senior care company NHC posts $381.8M in Q1 revenue, EPS hits $2.27
National HealthCare Corporation (NHC) announced Q1 2026 net operating revenues of $381.8 million, a 2.2% increase from the previous year. The company reported GAAP diluted earnings per share of $2.27, up from $2.07 in Q1 2025, and adjusted diluted EPS of $1.91, showing a 21.1% increase in adjusted net income. NHC continues to operate a wide range of senior care facilities and services across multiple states.
Earnings climb at National HealthCare (NYSE: NHC) with stronger Q1 2026 profit
National HealthCare Corporation (NHC) reported significantly stronger Q1 2026 financial results, with adjusted net income rising 21.1% to $30.1 million and adjusted diluted EPS increasing to $1.91. The company's net operating revenues grew 2.2% to $381.8 million, and it successfully eliminated all current and long-term debt, ending the quarter with $258.4 million in cash and marketable securities. NHC also raised its quarterly dividend per share to $0.64, supported by higher skilled nursing per-diem rates and patient days.
NHC SEC Filings - National Health 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for National HealthCare Corporation (NHC) SEC filings including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It highlights recent filings such as insider transactions by Stephen Flatt and J. Paul Abernathy, earnings press statements, and dividend declarations, along with AI-powered summaries and sentiment analysis for each document. The company operates various healthcare facilities and services, and its regulatory disclosures cover key financial and governance matters.
National HealthCare: Q1 Earnings Snapshot
National HealthCare Corp. (NHC) reported first-quarter earnings of $35.9 million, or $2.27 per share. Adjusted earnings were $1.91 per share, and the company posted revenue of $381.8 million for the period. These results were generated using data from Zacks Investment Research.
NHC Reports First Quarter 2026 Earnings
National HealthCare Corporation (NHC) announced its first quarter 2026 earnings, reporting increased net operating revenues of $381,821,000, up 2.2% from the previous year. The company's GAAP net income attributable to NHC rose to $35,857,000, and adjusted diluted earnings per share increased by 21.1% to $1.91. NHC, the nation's oldest publicly traded senior healthcare company, also noted its diverse operations including skilled nursing facilities, assisted living, and homecare agencies.
NHC Announces 4.7% Increase in Common Dividend
National HealthCare Corporation (NHC) has announced a 4.7% increase in its quarterly common dividend, raising it to 67 cents per share. This dividend will be paid on July 31, 2026, to shareholders of record as of June 30, 2026. The announcement includes forward-looking statements and details about NHC's operations, which encompass skilled nursing facilities, assisted living communities, and homecare agencies.
National HealthCare: Q1 Earnings Snapshot
National HealthCare Corp. (NHC) reported first-quarter earnings of $35.9 million, equating to $2.27 per share. Adjusted for non-recurring gains, earnings were $1.91 per share. The nursing home and assisted living company also recorded $381.8 million in revenue for the period.
[Form 4] NATIONAL HEALTHCARE CORP Insider Trading Activity
NATIONAL HEALTHCARE CORP director Emil E. Hassan received a new stock option grant on May 7, 2026, enabling him to purchase 7,500 shares at an exercise price of $171.42, vesting from May 7, 2027, and expiring May 6, 2031. Following this grant, he directly holds 73,095 shares of common stock and several prior option awards. The transaction is noted to have a neutral filing impact and sentiment.
Director at National Healthcare (NHC) granted 7,500 options at $171.42
Robert G. Adams, a director at National Healthcare Corp (NHC), was granted 7,500 stock options at an exercise price of $171.42 per share, expiring on May 6, 2031, under the company's 2020 Omnibus Equity Incentive Plan. This grant is a routine compensation award, and the filing indicates no open-market purchases or sales by Adams. He also retains prior option grants from 2022-2025 and indirect holdings in a trust and partnership.
67-cent payout arrives July 31 after National HealthCare raises dividend
National HealthCare Corporation (NHC) announced a 4.7% increase in its quarterly dividend, raising it to 67 cents per common share. The dividend will be paid on July 31, 2026, to shareholders of record as of June 30, 2026. NHC is the nation's oldest publicly traded long-term health care company, operating various facilities and services.
Dividend up 4.7% at National HealthCare (NYSE: NHC)
National HealthCare Corporation (NHC) has announced a 4.7% increase in its quarterly common dividend, raising it to $0.67 per share. Shareholders of record on June 30, 2026, will receive the payment on July 31, 2026. This move indicates the company's confidence in its ongoing cash generation and provides a steady income profile for investors, reflecting its diverse long-term care operations.
Director at NATIONAL HEALTHCARE (NHC) exercises options for 7,500 shares
Richard F. LaRoche Jr., a director at NATIONAL HEALTHCARE CORP (NHC), exercised stock options to acquire 7,500 shares of common stock at $71.64 per share on May 5, 2026. This transaction increased his direct holdings to 213,260 shares. LaRoche Jr. retains four additional option grants, each for 7,500 shares, with varying exercise prices and expiration dates through 2030, indicating a continued significant equity stake in the company.
[Form 4] NATIONAL HEALTHCARE CORP Insider Trading Activity
National Healthcare Corp. director Emil E. Hassan reported an exercise of 7,500 common stock options at $71.64 per share on April 30, 2026, increasing his direct holdings to 73,095 shares. This exercise fully utilized his 2021 option grant, while four other option grants remain outstanding with varying exercise prices and expiration dates between 2027 and 2030. The transaction, part of the 2020 Omnibus Equity Incentive Plan, is exempt from Section 16(b).
Vest Financial LLC Purchases 12,759 Shares of National HealthCare Corporation $NHC
Vest Financial LLC significantly increased its stake in National HealthCare Corporation by 101.4% in the fourth quarter, purchasing 12,759 additional shares, bringing their total holdings to 25,343 shares valued at approximately $3.47 million. The company, which is a healthcare services provider with a market capitalization of $2.73 billion, recently declared a quarterly dividend of $0.64 per share. Institutional investors collectively own 56.44% of National HealthCare's stock.
NATIONAL HEALTHCARE (NHC) Sr VP exercises options, now holds 18,412 shares
Vicki L. Dodson, Senior Vice President of Patient Services at NATIONAL HEALTHCARE CORP (NHC), exercised stock options to acquire 4,000 shares of common stock at $94.10 per share. To cover the exercise price and tax obligations, 2,853 shares were withheld by the company. Following these transactions, she directly holds approximately 18,412 shares and retains options for an additional 23,000 shares.
Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC).
Blueprint Healthcare Real Estate Advisors acted as the transaction advisor to National Health Investors, Inc. (NHI) for its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NHC). The portfolio includes 32 skilled nursing facilities and three independent living communities. This strategic move aims to provide NHI with greater financial flexibility and support its shift towards private-pay seniors housing assets, with the transaction expected to close on July 1, 2026.
National HealthCare (NYSEAMERICAN:NHC) Sets New 12-Month High - What's Next?
National HealthCare (NHC) recently hit a new 52-week high after announcing the acquisition of 35 skilled nursing and independent living facilities for $560 million, converting properties it currently leases into owned real estate. This strategic move, which is expected to boost revenue and operational synergies, led to an 8.1% intraday gain. However, the purchase also introduces risks related to financing, potential increased leverage, and operational challenges in integrating the new facilities.
Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC). – Company Announcement - FT.com
Blueprint Healthcare Real Estate Advisors is acting as the transaction advisor to National Health Investors, Inc. (NHI) for its planned $560 million divestiture of a 35-property healthcare portfolio to National HealthCare Corporation (NHC). This portfolio includes 32 skilled nursing facilities and three independent living communities, currently under a long-term master lease with NHC. The deal aims to provide NHI with greater financial flexibility and support its strategic shift towards private-pay seniors housing, with an expected closing date of July 1, 2026.
Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC).
Blueprint Healthcare Real Estate Advisors served as the transaction advisor to National Health Investors, Inc. (NHI) for its planned $560 million sale of a 35-property healthcare portfolio to National HealthCare Corporation (NHC). The portfolio includes 32 skilled nursing facilities and three independent living communities, currently operated by NHC under a long-term master lease. This strategic disposition is expected to enhance NHI's financial flexibility and support its shift towards private-pay seniors housing assets, with the transaction anticipated to close on July 1, 2026.
NHC (NHC) plans $560M buyout of 35 NHI facilities by Q3 2026
National HealthCare Corporation (NHC) plans to acquire 32 skilled nursing facilities and three independent living facilities from National Health Investors (NHI) for $560 million. This transaction will convert NHC from a tenant to an owner for most of these properties, which are currently leased in seven states. The deal, expected to close in Q3 2026, aims to be accretive to NHC's earnings and cash flow, providing greater operational flexibility.
NHC to Acquire Thirty-Five NHI Facilities
National HealthCare Corporation (NHC) announced its plan to acquire the real estate of 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. (NHI) for $560 million. This acquisition is expected to enhance NHC's long-term shareholder value and provide operational flexibility, with the transaction anticipated to close in the third quarter of 2026. NHC currently operates these facilities and intends to continue doing so, except for four Florida skilled nursing facilities that will remain under a third-party operator's lease.
NHC to acquire 35 senior care facilities for $560 million
National HealthCare Corporation (NHC) is set to acquire the real estate of 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. for $560 million. NHC, which currently leases and operates these facilities, expects the transaction to be accretive to both earnings and cash flow, leveraging its strong balance sheet with a low debt-to-equity ratio and consistent dividend increases. The acquisition, covering properties across seven states within NHC's existing footprint, is scheduled to close in the third quarter of 2026.
NHC bets $560M on senior-care real estate across 7 states
National HealthCare Corporation (NHC) announced its plan to acquire the real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors, Inc. (NHI) for $560 million. This acquisition is expected to enhance NHC's operational flexibility, be accretive to earnings and cash flow, and reinforce its commitment to shareholder value. The transaction, involving facilities across seven states, is anticipated to close in the third quarter of 2026.
NHI Announces Sale of NHC Portfolio for $560 Million
National Health Investors, Inc. (NHI) has agreed to sell a portfolio of 32 skilled nursing facilities and three independent living facilities to National HealthCare Corporation (NHC) for $560 million. This transaction aims to strengthen NHI's balance sheet, increase its focus on private-pay senior housing, and provide capital for future investments. The deal is expected to close on July 1, 2026, subject to customary closing conditions.
National Healthcare Corp (NHC) Shares Fall 3.6% -- GF Value Says Still Overvalued
National Healthcare Corp (NHC) shares fell 3.6% to $163.50, placing the stock significantly above its GF Value™ estimate of $123.71, indicating it is overvalued. Despite a strong GF Score™ of 82/100, reflecting robust financial strength and profitability, the valuation and lack of insider transactions suggest caution for investors. NHC's current P/E ratio also stands above its historical median, further supporting the overvalued assessment.
NHC (NHC) SVP amends Form 4 on 2,109-share tax withholding
National Healthcare Corp's Senior VP & CIO, Ben Anderson Flatt Sr, filed an amended Form 4 to correct a previous disclosure regarding shares withheld for taxes and exercise costs. The company withheld 2,109 shares of common stock at $176.81 per share for these obligations. After this correction, Flatt directly holds 21,175.0547 shares and retains option awards for 31,000 underlying shares.
National Healthcare (NHC) exec exercises options; company withholds shares for taxes
National Healthcare Corp's Senior VP & CIO, Ben Anderson Flatt Sr, exercised stock options for 3,734 shares at $53.94 each. To cover the exercise price and taxes, the company withheld 1,909 shares valued at $176.81 per share. Following these transactions, Flatt directly beneficially owns 21,375.0547 shares and retains other options expiring through 2031.
Is National HealthCare (NHC) Trading Above Intrinsic Value or Reflecting Its Underappreciated Quality Premium?
National HealthCare Corp's market price is currently above GuruFocus' estimated GF Value, prompting questions about its alignment with intrinsic value. While the company boasts strong financial health and profitability, concerns are rising that investors may be overpaying for these qualities. This valuation debate shapes the investment narrative, with the market reassessing the premium it's willing to pay for NHC's stability rather than reflecting a change in the underlying business.
Is National HealthCare (NHC) Trading Above Intrinsic Value or Reflecting Its Underappreciated Quality Premium?
National HealthCare Corp's market price is noted to be significantly above GuruFocus’ estimated GF Value, sparking debate on its alignment with intrinsic value and whether investors are overpaying for its strong financial health. The company, a mature and cash-generative operator, is characterized by consistent earnings and dividends, and the recent market reassessment primarily concerns the price investors are willing to pay for this stability rather than a change in the business fundamentals. Different fair value estimates from the Simply Wall St community highlight a wide range of opinions on its true worth, emphasizing the importance of diverse perspectives in investment decisions.
Is National HealthCare (NHC) Trading Above Intrinsic Value or Reflecting Its Underappreciated Quality Premium?
National HealthCare Corp's stock may be trading above its intrinsic value according to GuruFocus, despite strong financial performance. This raises questions for investors about paying a premium for stability and reliable dividends. The article urges investors to consider various fair value estimates and conduct thorough research to form their own conviction about NHC's investment potential.
National HealthCare Corp stock hits all-time high of 175.11 USD By Investing.com
National HealthCare Corp (NHC) stock reached a new all-time high of $175.11, despite being just 1% below its 52-week high. InvestingPro analysis indicates the healthcare provider is still undervalued, with its stock price delivering an impressive 87.75% total return over the past year. The company also declared a quarterly dividend of 64 cents per common share, payable on April 30, 2026, and operates 80 skilled nursing facilities across several states.
NHC PE Ratio & Valuation, Is NHC Overvalued
This article analyzes the valuation of National Healthcare Corp (NHC), stating that it is currently in the "Fair zone" based on its forward PS ratio compared to its five-year average. It details NHC's Price-to-Book ratio, Free Cash Flow yield, and compares its P/S ratio to competitor averages, suggesting that some premiums might be unsustainable given its revenue growth. The article also provides answers to frequently asked questions regarding NHC's valuation metrics as of April 1, 2026.
